Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Zanon

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
BMC Cancer|September 27, 2014
Mutational profiling of kinases in glioblastomaFonnet E Bleeker, Simona Lamba, Carlo Zanon, et al.
Cell Death and Differentiation|November 20, 2019
Correction to: LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursorsDiana Corallo, Michael Donadon, Marcella Pantile, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 20, 2022
Ambra1 deficiency impairs mitophagy in skeletal muscleLisa Gambarotto, Samuele Metti, Martina Chrisam, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Cells|October 23, 2021
Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case StudyDiana Corallo, Carlo Zanon, Marcella Pantile, et al.
Oncotarget|September 12, 2015
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancerMarco Agostini, Klaus-Peter Janssen, Il-Jin Kim, et al.
Cancer Biology & Therapy|May 30, 2015
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patientsMarco Agostini, Andrea Zangrando, Chiara Pastrello, et al.
Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Cells|July 13, 2026
Comparative Study of Single-Cell and Bulk RNA Sequencing Data from Metastatic Bone Marrow Neuroblastoma SamplesSanja Aveic, Alessandro Davini, Sara Menegazzo, et al.
Neuro-Oncology|February 11, 2014
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT aloneRemco J Molenaar, Dagmar Verbaan, Simona Lamba, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
BMC Cancer|September 27, 2014
Mutational profiling of kinases in glioblastomaFonnet E Bleeker, Simona Lamba, Carlo Zanon, et al.
Cell Death and Differentiation|November 20, 2019
Correction to: LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursorsDiana Corallo, Michael Donadon, Marcella Pantile, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 20, 2022
Ambra1 deficiency impairs mitophagy in skeletal muscleLisa Gambarotto, Samuele Metti, Martina Chrisam, et al.
Leukemia & Lymphoma|May 24, 2011
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjectsLudovica Riera, Elena Lasorsa, Lisa Bonello, et al.
Cells|October 23, 2021
Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case StudyDiana Corallo, Carlo Zanon, Marcella Pantile, et al.
Oncotarget|September 12, 2015
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancerMarco Agostini, Klaus-Peter Janssen, Il-Jin Kim, et al.
Cancer Biology & Therapy|May 30, 2015
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patientsMarco Agostini, Andrea Zangrando, Chiara Pastrello, et al.
Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Cells|July 13, 2026
Comparative Study of Single-Cell and Bulk RNA Sequencing Data from Metastatic Bone Marrow Neuroblastoma SamplesSanja Aveic, Alessandro Davini, Sara Menegazzo, et al.
Neuro-Oncology|February 11, 2014
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT aloneRemco J Molenaar, Dagmar Verbaan, Simona Lamba, et al.
Pageof 5